Men living in Spanish-speaking countries already have a men’s health book of accurate, up-to-date health information on prostate cancer in their language just for them.
“I wanted the best, so I did a lot of research. That’s why I chose St. Francis Hospital.” When 62-year-old Richard Lechner was diagnosed with…
Spotify Founder and CEO Daniel Ek knows a thing or two about growing a company from the ground up. And that’s exactly what he plans…
September is prostate cancer awareness month. It’s the second most common disease for men in the USA. About 1 in 7 men will be diagnosed…
Artificial intelligence is showing up all over the place. And now, Ukraine is using it in its war against Russia. Ukraine has successfully engineered and…
China’s Huawei Technologies is plotting a return to the 5G smartphone industry by the end of this year, according to research firms, signalling a comeback…
A controversial short film is raising eyebrows and questions about the use of “deepfakes” and generative AI. Created in just 7 days on a budget…
After the affirmative action and student debt decisions, the investment bank just wrote a scathing report on the landscape of higher education.
PRINCETON, N.J., June 26, 2023–BMS Receives European Commission Approval of CAMZYOS® (mavacamten), for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)
Amylyx Pharmaceuticals Canada announced today that the Company has entered into a Product Listing Agreement with Quebec for the public reimbursement of ALBRIOZA™ (sodium phenylbutyrate…
The integration of artificial intelligence (AI) with wearable technology is rising. Many watch-style wearable tracking devices can use AI to monitor vital signs and use…
